Prognostic method

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9109257
APP PUB NO 20100185429A1
SERIAL NO

12309208

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method for prognosing recurrence of prostate cancer (PCa) in a subject following prostatectomy using the outcomes of selected single nucleotide polymorphisms (SNPs) and clinical variables. A method for genotyping PCa associated genetic variations comprising use of a DNA microarray. A microarray for use in the described methods.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PROGENIKA BIOPHARMA S APARQUE TECNOLOGICO DE BIZKAIA EDIFICIO 504 DERIO 48160

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Amo, Jokin Del Getxo, ES 1 0
Martínez, Martínez Antonio Vizcaya, ES 6 4
Robles, Juan Morote Barcelona, ES 2 0
Simón, Buela Laureano Guipúzcoa, ES 8 9
Tejedor, Hernández Diego Vizcaya, ES 5 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 18, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00